Global acute respiratory infection market expected to reach USD 20.8 trillion by 2033

The global market for acute respiratory infections is projected to grow from approximately USD 18,458.1 billion in 2023 to around USD 20,796.6 billion by 2033, with a compound annual growth rate of 1.2%. Key factors driving this growth include the high prevalence of respiratory diseases, an aging population, and increased healthcare spending. Technological advancements in diagnostics and pandemic preparedness also contribute to market expansion. Recent developments include new diagnostic tests and treatments introduced by companies like QuantuMDx and Roche, aimed at improving rapid testing and managing respiratory infections effectively.